TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33991686

Group type: EXPERIMENTAL
Intervention: Patient-centered mobile health technology intervention (iCardia4HF) including Heart Failure Storylines app, connected health devices (Withings weight scale, blood pressure monitor, Fitbit activity tracker), and tailored text messages
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group receiving connected health devices without the HF self-care app and text messages
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Patient-centered mobile health technology intervention (iCardia4HF)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 92
Study: 35428613

Group type: EXPERIMENTAL
Intervention: Co-amoxiclav 400/57 suspension
Number of subjects: 271

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 271
Study: 33121997

Group type: EXPERIMENTAL
Intervention: 3-month CAPOX
Number of subjects: 514

Group type: COMPARATOR
Intervention: 6-month CAPOX
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: 3-month mFOLFOX6
Number of subjects: 514

Group type: COMPARATOR
Intervention: 6-month mFOLFOX6
Number of subjects: 514
Study: 32252680

Group type: EXPERIMENTAL
Intervention: Concurrent EP (etoposide + cisplatin) chemotherapy with intensity-modulated radiation therapy (IMRT)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Concurrent PC (paclitaxel + carboplatin) chemotherapy with intensity-modulated radiation therapy (IMRT)
Number of subjects: 71
Study: 33988909

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention for elderly Alzheimer Disease patients
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention for caregivers of elderly Alzheimer Disease patients
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine intervention (Control group)
Number of subjects: 150
Study: 34237489

Group type: EXPERIMENTAL
Intervention: Logistic regression model and elastic net regression model
Number of subjects: 1055

Group type: EXPERIMENTAL
Intervention: Elastic net algorithm
Number of subjects: 1055

Group type: EXPERIMENTAL
Intervention: Prognostic score calculation
Number of subjects: 1055

Group type: EXPERIMENTAL
Intervention: Bootstrapping internal verification method (R = 1000)
Number of subjects: 1055
Study: 35945745

Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with intravenous ibuprofen (10 mg/kg) administered once within 6 hours after birth
Number of subjects: 69

Group type: COMPARATOR
Intervention: Non-prophylactic treatment (non-PT)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with intravenous ibuprofen (10 mg/kg)
Number of subjects: 69
Study: 34911530

Group type: EXPERIMENTAL
Intervention: Guided approach to periodontal infection control (GPIC)
Number of subjects: 494

Group type: COMPARATOR
Intervention: Conventional non-surgical therapy (CNST)
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Both GPIC and CNST
Number of subjects: 494
Study: 35441313

Group type: EXPERIMENTAL
Intervention: Xenon anesthesia
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 24
Study: 33604941

Group type: EXPERIMENTAL
Intervention: Twice-daily regimen (UFT 300 mg/m2 per day, LV 50 mg per day)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Three-times-daily regimen (UFT 300 mg/m2 per day, LV 75 mg per day)
Number of subjects: 386
Study: 35879001

Group type: EXPERIMENTAL
Intervention: Trained palliative care educators and video decision aids
Number of subjects: 9000
Study: 33453756

Group type: EXPERIMENTAL
Intervention: Pembrolizumab with radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pembrolizumab without radiotherapy
Number of subjects: 0
Study: 32739049

Group type: EXPERIMENTAL
Intervention: GSK1795091 (30 participants)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (10 participants)
Number of subjects: 40
Study: 35927627

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC) + best medical treatment (BMT)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Best medical treatment (BMT)
Number of subjects: 200
Study: 32990234

Group type: EXPERIMENTAL
Intervention: Modeling group (n=120)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Validation group (n=60)
Number of subjects: 180
Study: 35013089

Group type: EXPERIMENTAL
Intervention: TI-CBT Enhanced (TI-CBTe)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Usual Care (time-matched, unstructured support groups)
Number of subjects: 356
Study: 34324933

Group type: EXPERIMENTAL
Intervention: Fentanyl (2 μg.kg-1) followed by propofol (1 mg.kg-1) after 1 minute
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Fentanyl (2 μg.kg-1) followed by propofol (2 mg.kg-1) after 2 minutes
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: All groups (1 min and 2 min with varying doses of propofol)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 186
Study: 32167611

Group type: EXPERIMENTAL
Intervention: Full-energy enteral feeding starting at 75% of daily energy expenditure, increasing to 90%-100%.
Number of subjects: 58

Group type: COMPARATOR
Intervention: Hypocaloric enteral feeding starting with 30% of daily energy expenditure, reaching 75% within 7 days.
Number of subjects: 58

Group type: COMPARATOR
Intervention: Full-energy enteral feeding (control group).
Number of subjects: 58
Study: 35176136

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus chemotherapy
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Cetuximab plus chemotherapy
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Both Bevacizumab and Cetuximab plus chemotherapy
Number of subjects: 554
Study: 34493225

Group type: EXPERIMENTAL
Intervention: Saving Babies? Lives programme (intervention)
Number of subjects: 6615

Group type: COMPARATOR
Intervention: Standard government service (control)
Number of subjects: 6615
Study: 34706141

Group type: EXPERIMENTAL
Intervention: Sunitinib in the deferred arm (n=48)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sunitinib in the immediate arm (n=40)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Immediate CN
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Deferred CN
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sunitinib treatment duration in immediate arm
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Sunitinib treatment duration in deferred arm
Number of subjects: 88
Study: 34545166

Group type: EXPERIMENTAL
Intervention: Regular AVG training (AVG-R)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Enhanced AVG training (AVG+)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Treatment-as-usual comparison group
Number of subjects: 64
Study: 36420043

Group type: EXPERIMENTAL
Intervention: infant‐mCIMT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: infant‐BIT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: infant‐hybrid
Number of subjects: 0

Group type: COMPARATOR
Intervention: infant standard therapy
Number of subjects: 0
Study: 32193820

Group type: EXPERIMENTAL
Intervention: SRP + DL
Number of subjects: 60

Group type: COMPARATOR
Intervention: SRP
Number of subjects: 60
Study: 36058824

Group type: EXPERIMENTAL
Intervention: Abdominal massage with ginger and lavender oil for 15 min, 5 weekdays per week for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 40
Study: 36482652

Group type: EXPERIMENTAL
Intervention: Face-to-face intubation
Number of subjects: 76

Group type: COMPARATOR
Intervention: Routine intubation
Number of subjects: 76
Study: 33693616

Group type: EXPERIMENTAL
Intervention: Adapted Self-Reporting Questionnaire (SRQ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adapted Kessler-6 screening questionnaire
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both questionnaires
Number of subjects: 0
Study: 35448895

Group type: EXPERIMENTAL
Intervention: Intracavernosal incobotulinumtoxinA (Xeomin®) 100 U as an add-on therapy
Number of subjects: 66
Study: 34217604

Group type: EXPERIMENTAL
Intervention: Education on mammographic positioning
Number of subjects: 24
Study: 32777664

Group type: EXPERIMENTAL
Intervention: App group (UroHealth app)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (validated printed questionnaires)
Number of subjects: 100
Study: 35989239

Group type: EXPERIMENTAL
Intervention: Motor exercises for five weeks
Number of subjects: 70
Study: 33529664

Group type: EXPERIMENTAL
Intervention: Apixaban (2.5 mg dose)
Number of subjects: 2058

Group type: EXPERIMENTAL
Intervention: Apixaban concentration
Number of subjects: 2058

Group type: EXPERIMENTAL
Intervention: Anti-Factor Xa activity
Number of subjects: 2058

Group type: EXPERIMENTAL
Intervention: Chromogenic anti-Factor Xa activity assay
Number of subjects: 2058

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 2058
Study: 34986793

Group type: EXPERIMENTAL
Intervention: Catheter-over-needle (CON) technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Catheter-through-needle (CTN) technique
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups received CFNB and sciatic nerve block with 0.16% levobupivacaine and 6 mg indigo carmine at 6 ml/h
Number of subjects: 60
Study: 33136703

Group type: EXPERIMENTAL
Intervention: Follow-up at 1 month
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Follow-up at 6 months
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Follow-up at 12 months
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Follow-up at 18 months
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Association with fatigue
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Association with depressive symptoms
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Association with quality of life
Number of subjects: 734
Study: 32970172

Group type: EXPERIMENTAL
Intervention: β‐lactam antibiotic treatment for less than seven days
Number of subjects: 16

Group type: COMPARATOR
Intervention: No antibiotic treatment
Number of subjects: 16
Study: 35583488

Group type: EXPERIMENTAL
Intervention: Anabolic-androgenic steroids (AAS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 33627069

Group type: EXPERIMENTAL
Intervention: FindMyApps intervention (tablet computer and FindMyApps)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care (control arm - tablet computer)
Number of subjects: 150
Study: 32757479

Group type: EXPERIMENTAL
Intervention: Capsaicin plus ice stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ice stimulation (control)
Number of subjects: 0
Study: 35215431

Group type: EXPERIMENTAL
Intervention: 50% taro flour + 50% wheat flour
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 50% taro flour + 50% wheat flour + probiotic L. plantarum IS‐10506
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 50% taro flour + 50% wheat flour + beetroot adsorbed
Number of subjects: 15
Study: 34078342

Group type: COMPARATOR
Intervention: Physical activity intervention (iPA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sedentary behaviour intervention (iSED)
Number of subjects: 0
Study: 32719251

Group type: EXPERIMENTAL
Intervention: Ayurvedic preparation Yashtimadhu in addition to conventional treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional mucositis treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Honey for local application and oral intake in addition to routine conventional treatment
Number of subjects: 0
Study: 35110418

Group type: EXPERIMENTAL
Intervention: RO4929097 plus vismodegib
Number of subjects: 73

Group type: COMPARATOR
Intervention: RO4929097 alone
Number of subjects: 73
Study: 33621332

Group type: EXPERIMENTAL
Intervention: Meditation and Exercise Treatment (MedExT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Audiobook Control
Number of subjects: 38
Study: 32340585

Group type: EXPERIMENTAL
Intervention: Action Observation (AO)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Cervical Exercise (AE)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 54

Group type: COMPARATOR
Intervention: All groups (including Control)
Number of subjects: 54
Study: 35372428

Group type: EXPERIMENTAL
Intervention: Memory Foam Pillow (MFP)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Own Pillow (OP)
Number of subjects: 32
Study: 33092813

Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Transcutaneous posterior tibial nerve stimulation (TPTNS)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Dietetic regulation and Kegal exercises
Number of subjects: 93
Study: 34712343

Group type: EXPERIMENTAL
Intervention: Harpagophytum procumbens (Teltonal) 2 tablets (2*480 mg) daily for one month
Number of subjects: 60

Group type: COMPARATOR
Intervention: meloxicam 15 mg daily for ten days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Harpagophytum procumbens (Teltonal)
Number of subjects: 60

Group type: COMPARATOR
Intervention: meloxicam
Number of subjects: 60
Study: 34010183

Group type: EXPERIMENTAL
Intervention: ACEI/ARB treatment after PCI
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: ACEI/ARB treatment after CABG
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: No ACEI/ARB treatment after PCI
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: No ACEI/ARB treatment after CABG
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: ACEI/ARB treatment
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: No ACEI/ARB treatment
Number of subjects: 1905
Study: 34949637

Group type: EXPERIMENTAL
Intervention: Two-stage consent pathway (oral assent followed by informed written consent)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standardised information and written record
Number of subjects: 0
Study: 32609361

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/day
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 32522591

Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standardized Episodic Thinking (SET)
Number of subjects: 60

Group type: COMPARATOR
Intervention: DASH diet education
Number of subjects: 60

Group type: COMPARATOR
Intervention: DASH diet education crossed with EFT
Number of subjects: 60
Study: 36000981

Group type: EXPERIMENTAL
Intervention: ACT-1014-6470 (60 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 32045260

Group type: EXPERIMENTAL
Intervention: PITSTOP mindfulness training video
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control video on ways to increase physical activity
Number of subjects: 26
Study: 33707543

Group type: EXPERIMENTAL
Intervention: Machine Learning methodologies (Random Forests, Extremely Randomized Trees, Boosted Trees, Logistic Regression)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional multivariate approach (discriminant analysis model)
Number of subjects: 0
Study: 32399853

Group type: EXPERIMENTAL
Intervention: SUVN-G3031 (6 mg once daily for multiple doses)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SUVN-G3031 (up to 20 mg for single doses)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SUVN-G3031 (multiple doses)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SUVN-G3031
Number of subjects: 100
Study: 35046190

Group type: EXPERIMENTAL
Intervention: Kinesio Taping
Number of subjects: 30

Group type: COMPARATOR
Intervention: Exercises
Number of subjects: 30
Study: 34536664

Group type: EXPERIMENTAL
Intervention: Cannabidiol (0.25 ml, 5% cannabidiol, 12.5 mg cannabidiol)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cannabidiol
Number of subjects: 39
Study: 35944722

Group type: EXPERIMENTAL
Intervention: Universal screening using the Patient Health Questionnaire‐9 (PHQ‐9)
Number of subjects: 12909

Group type: COMPARATOR
Intervention: Usual school practice of targeted referral for behavior raising a concern for suicide risk
Number of subjects: 12909
Study: 33325185

Group type: EXPERIMENTAL
Intervention: Negative metastereotype activation (NMSA)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Non-NMSA condition
Number of subjects: 124
Study: 33954449

Group type: EXPERIMENTAL
Intervention: Barley Recombinant Inbred Diverse Germplasm Population (BRIDG6)
Number of subjects: 6160

Group type: EXPERIMENTAL
Intervention: Haplotype-based analysis of HvPpd-H1
Number of subjects: 6160

Group type: EXPERIMENTAL
Intervention: Sample size evaluation for QTL detection
Number of subjects: 6160
Study: 36099166

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 0
Study: 34174349

Group type: EXPERIMENTAL
Intervention: Infiltration (Icon; DMG)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Mock (control) treatment
Number of subjects: 87
Study: 33095633

Group type: EXPERIMENTAL
Intervention: Certification methods for quantum state preparation and measurement devices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized version of unambiguous state discrimination
Number of subjects: 0
Study: 33879769

Group type: EXPERIMENTAL
Intervention: SEP-363856 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SEP-363856 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 34061684

Group type: EXPERIMENTAL
Intervention: 30SMA (social media applications on smartphones)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 30VID (videogames)
Number of subjects: 21

Group type: COMPARATOR
Intervention: CON (coaching videos)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: All conditions (30SMA, 30VID, CON)
Number of subjects: 21
Study: 33550967

Group type: COMPARATOR
Intervention: hsa-miR-129-2 and hsa-miR-889 expression levels in exosomes
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Six independent prognosis-associated miRNAs in exosomes
Number of subjects: 491

Group type: COMPARATOR
Intervention: Differentially expressed mRNAs (DEGs) and miRNAs (DEMs)
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: miRNA-mRNA co-expression network
Number of subjects: 491
Study: 33136966

Group type: EXPERIMENTAL
Intervention: Targeted muscle reinnervation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Historical gold standard (excision and burying the involved nerve in muscle)
Number of subjects: 0
Study: 35513191

Group type: EXPERIMENTAL
Intervention: Racial discrimination experienced by Black parents at wave 1
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Parent–child conflict at wave 2
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Racial discrimination experienced by Black parents
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Multiple outcomes (depression, anxiety, conduct problems)
Number of subjects: 252
Study: 33651026

Group type: EXPERIMENTAL
Intervention: Dry storage overnight
Number of subjects: 10

Group type: COMPARATOR
Intervention: Wet storage overnight
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dry storage followed by immersion in water for 15 minutes
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Wet storage followed by immersion in water for 15 minutes
Number of subjects: 10
Study: 32487179

Group type: EXPERIMENTAL
Intervention: PEERS® social skills intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Active control condition (puberty psychoeducation group training)
Number of subjects: 150
Study: 36344851

Group type: EXPERIMENTAL
Intervention: R0 resection and lenvatinib-transarterial chemoembolization (lenvatinib-TACE) sequential therapy
Number of subjects: 83

Group type: COMPARATOR
Intervention: Other non-curative-intent subsequent treatment
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: R0 resection and lenvatinib-TACE sequential therapy
Number of subjects: 83

Group type: COMPARATOR
Intervention: Non-curative-intent subsequent treatment
Number of subjects: 83
Study: 34981493

Group type: EXPERIMENTAL
Intervention: Olive oil ointment (85% olive oil), applied twice a day for 4 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo ointment (85% liquid paraffin, similar in color and odor to olive oil ointment), applied twice a day for 4 days
Number of subjects: 40
Study: 33998912

Group type: EXPERIMENTAL
Intervention: Empowered Conversations (EC) course
Number of subjects: 159
Study: 32200457

Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic Hartmann's reversal (SP-HR)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Multi-port laparoscopic Hartmann's reversal (MP-HR)
Number of subjects: 44
Study: 36029646

Group type: EXPERIMENTAL
Intervention: Dengzhan Shengmai (DZSM) capsules
Number of subjects: 150

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 150
Study: 33508236

Group type: EXPERIMENTAL
Intervention: Superficial nerve block (SNB) with 1.8 mL of 2% lidocaine and 1:100,000 epinephrine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional technique (CT) with 1.8 mL of 2% lidocaine and 1:100,000 epinephrine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Superficial nerve block (SNB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional technique (CT)
Number of subjects: 20
Study: 32590385

Group type: EXPERIMENTAL
Intervention: Transpulmonary pressure-guided ventilation
Number of subjects: 102

Group type: COMPARATOR
Intervention: Lung rest strategy
Number of subjects: 102
Study: 35272960

Group type: EXPERIMENTAL
Intervention: Experienced examiners
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Novice examiners
Number of subjects: 34

Group type: COMPARATOR
Intervention: Novice vs Experienced examiners
Number of subjects: 34
Study: 34014956

Group type: EXPERIMENTAL
Intervention: Community-based intervention (CBI)
Number of subjects: 973

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 973
Study: 32553868

Group type: EXPERIMENTAL
Intervention: CHF5633
Number of subjects: 123

Group type: COMPARATOR
Intervention: Poractant alfa
Number of subjects: 123
Study: 32781892

Group type: EXPERIMENTAL
Intervention: Telemedicine-delivered healthy lifestyle programme
Number of subjects: 0
Study: 34320935

Group type: EXPERIMENTAL
Intervention: TEPS (Temporal Experience of Pleasure Scale)
Number of subjects: 7410
Study: 35896985

Group type: EXPERIMENTAL
Intervention: Migraine patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Chronic migraine patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Episodic migraine patients
Number of subjects: 30
Study: 34979245

Group type: COMPARATOR
Intervention: High-definition white light colonoscopy (HDWLE)
Number of subjects: 1203

Group type: EXPERIMENTAL
Intervention: Cuff-assisted colonoscopy (CF)
Number of subjects: 1203

Group type: EXPERIMENTAL
Intervention: Cap-assisted colonoscopy (CP)
Number of subjects: 1203